| 2018 | Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
| 김경식, 김성훈, 김은경, 김효송, 노성훈, 라선영, 서진석, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁 |
| 2018 | BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
| 라선영, 안중배 |
| 2018 | Reconsideration of sample size and power calculation for overall survival in cancer clinical trials
| 남정모, 라선영, 정인경 |
| 2018 | CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
| 김남규, 김태일, 라선영, 박규현, 신상준, 안중배, 이강영 |
| 2018 | Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
| 김형일, 김효송, 노성훈, 라선영, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정희철, 최승호, 최윤영, 형우진 |
| 2018 | Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor | 김태수, 라선영, 정현철, 정희철 |
| 2018 | Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee.
| 김효송, 라선영 |
| 2018 | The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status | 김효송, 라선영, 범승훈, 윤미진, 이충근, 정민규, 정현철, 조응혁 |
| 2018 | A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy | 김승섭, 김효송, 남정모, 라선영, 박경수, 정민규, 정재호, 정현철, 채동우 |
| 2018 | Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer
| 라선영, 정현철 |
| 2018 | Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
| 노미령, 라선영, 신상준, 오병호, 이시형, 정기양 |
| 2018 | Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial | 김효송, 라선영, 정민규, 정현철 |
| 2018 | Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer | 김태수, 라선영, 박규현, 정민규, 정현철 |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | 김건민, 김혜련, 라선영, 손주혁 |
| 2018 | Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial | 김지형, 김형일, 김효송, 노성훈, 라선영, 박형순, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정현철, 최은아, 허수진, 형우진 |
| 2018 | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | 강윤구, 라선영, 정민규, 조재용 |
| 2018 | MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. | 김한상, 김현기, 라선영, 정현철 |
| 2018 | Rab25 augments cancer cell invasiveness through a beta1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin | 라선영, 정재호 |
| 2017 | A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors | 라선영, 정현철 |
| 2017 | A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors | 김건민, 라선영, 신상준, 안중배, 정현철 |
| 2017 | Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer | 금웅섭, 김효송, 노성훈, 라선영, 윤홍인, 이용찬, 임준석, 장지석, 형우진 |
| 2017 | Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma | 김경식, 김민환, 김효송, 라선영, 최영득 |
| 2017 | ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition | 김태수, 라선영, 안중배, 정현철, 정희철 |
| 2017 | Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
| 노미령, 라선영, 박규현, 신상준, 정기양 |
| 2017 | PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
| 김주훈, 김태수, 라선영, 박형순, 이충근, 정현철, 허수진 |
| 2017 | Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. | 강원준, 라선영, 윤미진, 조응혁, 최영득 |
| 2017 | Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
| 김지현, 김현기, 노성훈, 라선영, 박소희, 안중배, 전홍재, 정현철, 정희철, 형우진 |
| 2017 | Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
| 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박규현, 박준철, 배수진, 백순명, 범승훈, 손태일, 신성관, 이상길, 이용찬, 이은영, 이한나, 임준석, 정민규, 정재호, 정현철, 최윤영, 형우진 |
| 2017 | Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
| 강석민, 김지형, 김효송, 라선영, 박형순, 범승훈, 심지영, 이충근, 정민규, 정현철, 허수진, 홍그루 |
| 2017 | Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer | 금웅섭, 김효송, 라선영, 윤홍인, 이용찬, 임준석, 형우진 |
| 2017 | Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab
| 김승섭, 김현기, 김효송, 라선영, 박소희, 이충근, 임준석, 정민규, 정현철, 허수진 |
| 2017 | Prevalence and prognostic implications of psychological distress in patients with gastric cancer
| 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철 |
| 2017 | Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
| 김태수, 노재경, 라선영, 박규현, 신상준, 안중배, 정현철, 정희철 |
| 2017 | Characterizing the outcomes of metastatic papillary renal cell carcinoma | 라선영 |
| 2017 | Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life | 라선영 |
| 2017 | Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma | 라선영 |
| 2017 | Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
| 라선영 |
| 2017 | Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma | 라선영 |
| 2017 | Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines | 김태수, 라선영, 정현철, 정희철 |
| 2016 | Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy | 김형일, 김효송, 노성훈, 라선영, 안지영, 이충근, 정민규, 정용휴, 정인경, 정재호, 정현철, 허수진, 형우진 |
| 2016 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells
| 라선영 |
| 2016 | p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer | 김남규, 김태일, 노재경, 라선영, 박규현, 신상준, 안중배, 이강영 |
| 2016 | Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. | 김지형, 김혜련, 노성훈, 라선영, 송수경, 송승은, 이유미, 이호선 |
| 2016 | Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
| 라선영, 정현주, 조남훈, 최영득 |
| 2016 | Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
| 김경식, 김성훈, 김효송, 노성훈, 라선영, 범승훈, 서진석, 신규호, 오윤정, 이영한, 조영진, 최영득, 허혁 |
| 2016 | Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
| 김경식, 김성훈, 김주훈, 김효송, 노성훈, 라선영, 박규현, 서진석, 신규호, 안중배, 이영한, 최영득, 허혁 |
| 2016 | Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma. | 김현기, 김형일, 김효송, 노성훈, 라선영, 윤미진, 정민규, 정재호, 정현철, 조응혁, 형우진 |
| 2016 | Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma | 김경식, 김성훈, 김효송, 노성훈, 라선영, 서진석, 신규호, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁 |
| 2016 | High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer | 김남규, 라선영, 신상준, 안중배, 이강영, 정현철, 정희철 |
| 2016 | Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration | 금기창, 금웅섭, 김효송, 노성훈, 라선영, 이용찬, 임준석, 장지석, 형우진 |
(Yonsei Health Research Network)
